US OptionsDetailed Quotes
APLS240816P20000
- 0.24
- 0.000.00%
15min DelayClose Aug 16 15:59 ET
0.00High0.00Low
0.24Open0.24Pre Close0 Volume1 Open Interest20.00Strike Price0.00Turnover5603.70%IV46.95%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.24Extrinsic Value100Contract SizeAmericanOptions Type-0.0361Delta0.0055Gamma155.21Leverage Ratio-31.3967Theta0.0000Rho-5.60Eff Leverage0.0002Vega
Apellis Pharmaceuticals Stock Discussion
Sign in to post a comment
$Emergent BioSolutions (EBS.US)$👀 big news out WHO Says Expert Committee Will Propose Adopti - moomoo $Apellis Pharmaceuticals (APLS.US)$ $Puma Biotechnology (PBYI.US)$ $Novocure (NVCR.US)$
1
$Apellis Pharmaceuticals (APLS.US)$ CORRECTION: Apellis Pharmaceuticals Q2 2024 GAAP EPS $(0.30) Beats $(0.32) Estimate, Sales $199.70M Beat $191.51M Estimate
2
$Apellis Pharmaceuticals (APLS.US)$ 🥱 as i was saying the other day
1
4
2X 
$Apellis Pharmaceuticals (APLS.US)$ i made a lot of money on this stock
1
$Apellis Pharmaceuticals (APLS.US)$ I'm shocked this had not done anything. it hit bottom at 19.83 after the big scare panic sell off from mid 80s , bounce back up past 70. stupid corporate keeps selling off scaring investors. this is actually bargain price for this company
2
No comment yet
EZ_money OP : Vaccine developers for monkeypox include Bavarian Nordic (OTCPK:BVNKF) (OTCPK:BVNRY), Emergent BioSolutions (EBS), and Chimerix (CMRX).